Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (Nasdaq: AKBA) will release its third quarter 2025 financial results for the period ended September 30, 2025 on Monday, November 10, 2025 prior to market open.
The company will host a conference call on November 10, 2025 at 8:00 a.m. EST to discuss results and recent business highlights. Investors are asked to register for dial‑in details and to dial in 15 minutes early to avoid delays. A live webcast and an online archive will be available in the Investors section at https://ir.akebia.com/.
Akebia Therapeutics (Nasdaq: AKBA) pubblicherà i risultati finanziari del terzo trimestre 2025 per il periodo terminato 30 settembre 2025 lunedì 10 novembre 2025 prima dell'apertura del mercato.
L'azienda terrà una conference call il 10 novembre 2025 alle 08:00 EST per discutere i risultati e i recenti dati aziendali. Gli investitori sono invitati a registrarsi per i dettagli di accesso e a chiamare 15 minuti prima per evitare ritardi. Una trasmissione in diretta e un archivio online saranno disponibili nella sezione Investitori su https://ir.akebia.com/.
Akebia Therapeutics (Nasdaq: AKBA) publicará sus resultados financieros del tercer trimestre de 2025 para el periodo terminado el 30 de septiembre de 2025 el lunes 10 de noviembre de 2025 antes de la apertura del mercado.
La empresa llevará a cabo una conferencia telefónica el 10 de noviembre de 2025 a las 8:00 a.m. EST para discutir resultados y los aspectos comerciales recientes. Se solicita a los inversores que se registren para obtener los detalles de marcación y que llamen 15 minutos antes para evitar demoras. Una transmisión en vivo y un archivo en línea estarán disponibles en la sección de Inversores en https://ir.akebia.com/.
에이케비아 치료제(나스닥: AKBA)는 2025년 9월 30일에 종료된 기간의 2025년 3분기 재무 결과를 2025년 11월 10일 월요일 앞으로 시장 개장 전에 발표할 예정입니다.
회사는 2025년 11월 10일 오전 8:00 EST에 컨퍼런스 콜을 주최하여 결과와 최근 비즈니스 하이라이트를 논의할 예정입니다. 투자자들은 다이얼인 상세 정보를 등록하고 지연 방지를 위해 15분 일찍 전화로 연결하라고 요청받았습니다. 생방송 웹캐스트와 온라인 아카이브가 투자자 섹션의 https://ir.akebia.com/에서 제공될 예정입니다.
Akebia Therapeutics (Nasdaq : AKBA) publiera ses résultats financiers du troisième trimestre 2025 pour la période se terminant le 30 septembre 2025 le lundi 10 novembre 2025 avant l'ouverture du marché.
La société organisera une conférence téléphonique le 10 novembre 2025 à 8h00 EST pour discuter des résultats et des principaux faits marquants récents. Les investisseurs sont priés de s'inscrire pour obtenir les détails de connexion et d'appeler 15 minutes avant pour éviter les retards. Une retransmission en direct et une archive en ligne seront disponibles dans la section Investisseurs sur https://ir.akebia.com/.
Akebia Therapeutics (Nasdaq: AKBA) wird seine Finanzergebnisse des dritten Quartals 2025 für den Zeitraum bis zum 30. September 2025 am Montag, dem 10. November 2025 vor Handelsbeginn veröffentlichen.
Das Unternehmen wird am 10. November 2025 um 8:00 Uhr EST einen Conference Call abhalten, um Ergebnisse und aktuelle Geschäftshöhepunkte zu besprechen. Investoren werden gebeten, sich für Dial-in-Details zu registrieren und sich 15 Minuten vorher einzuwählen, um Verzögerungen zu vermeiden. Eine Live-Webcast und ein Online-Archiv werden im Bereich «Investoren» unter https://ir.akebia.com/ verfügbar sein.
أكيبيا ثيرابيوتيكس (ناسداك: AKBA) ستصدر نتائجها المالية للربع الثالث من عام 2025 للفترة المنتهية في 30 سبتمبر 2025 في الاثنين 10 نوفمبر 2025 قبل فتح السوق.
ستستضيف الشركة مكالمة مؤتمر في 10 نوفمبر 2025 الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة لمناقشة النتائج والإنجازات التجارية الأخيرة. يُطلب من المستثمرين التسجيل للحصول على تفاصيل الاتصال والاتصال قبل 15 دقيقة لتجنب التأخيرات. ستكون هناك بث مباشر وأرشيف عبر الإنترنت في قسم المستثمرين على https://ir.akebia.com/.
- None.
- None.
Akebia to Host Conference Call on November 10, 2025, at 8:00 a.m. EST
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, prior to the open of financial markets.
Akebia will host a conference call on Monday, November 10, 2025, at 8:00 a.m. EST to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at https://akebia.com/, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When will Akebia (AKBA) report Q3 2025 results?
What time is the Akebia (AKBA) conference call on November 10, 2025?
How can investors access the Akebia (AKBA) Q3 2025 webcast?
Do I need to register to join the Akebia (AKBA) conference call on November 10, 2025?
Will the Akebia (AKBA) conference call be archived for later viewing?
